
Article 1 
By way of derogation from Article 4(1) of Regulation (EC) No 1451/2007, France may allow the placing on the market of biocidal products containing Temephos (EC No 222-191-1; CAS No 3383-96-8), for vector mosquito control in the French overseas departments until 14 May 2010.
Article 2 

1. When allowing the placing on the market of biocidal products containing temephos in accordance with Article 1, France shall ensure that the following conditions are complied with:
(a) continued use is only possible under the conditions that biocidal products containing temephos are approved for the intended essential use;
(b) the continued use is only accepted so far as it has no unacceptable effect on human or animal health or on the environment;
(c) all appropriate risk reduction measures are imposed when granting approval;
(d) such biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the restricted use conditions;
(e) where appropriate, alternatives for such uses are being sought by the holders of the approvals or by France.
2. At the latest by 14 May 2010, France shall inform the Commission on the application of paragraph 1 and in particular on the actions taken pursuant to point (e) of that paragraph.
Article 3 
This Decision is addressed to the French Republic.
Done at Brussels, 14 May 2009.
For the Commission
Stavros DIMAS
Member of the Commission